In situ Formation of Polymer Microparticles in Bacterial Nanocellulose Using Alternative and Sustainable Solvents to Incorporate Lipophilic Drugs
Bacterial nanocellulose has been widely investigated in drug delivery, but the incorporation of lipophilic drugs and controlling release kinetics still remain a challenge. The inclusion of polymer particles to encapsulate drugs could address both problems but is reported sparely. In the present stud...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_d94e7b4cce28493c834e442d45c52c68 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Tom Bellmann |e author |
700 | 1 | 0 | |a Jana Thamm |e author |
700 | 1 | 0 | |a Uwe Beekmann |e author |
700 | 1 | 0 | |a Dana Kralisch |e author |
700 | 1 | 0 | |a Dagmar Fischer |e author |
245 | 0 | 0 | |a In situ Formation of Polymer Microparticles in Bacterial Nanocellulose Using Alternative and Sustainable Solvents to Incorporate Lipophilic Drugs |
260 | |b MDPI AG, |c 2023-02-01T00:00:00Z. | ||
500 | |a 10.3390/pharmaceutics15020559 | ||
500 | |a 1999-4923 | ||
520 | |a Bacterial nanocellulose has been widely investigated in drug delivery, but the incorporation of lipophilic drugs and controlling release kinetics still remain a challenge. The inclusion of polymer particles to encapsulate drugs could address both problems but is reported sparely. In the present study, a formulation approach based on in situ precipitation of poly(lactic-co-glycolic acid) within bacterial nanocellulose was developed using and comparing the conventional solvent <i>N</i>-methyl-2-pyrrolidone and the alternative solvents poly(ethylene glycol), Cyrene<sup>TM</sup> and ethyl lactate. Using the best-performing solvents <i>N</i>-methyl-2-pyrrolidone and ethyl lactate, their fast diffusion during phase inversion led to the formation of homogenously distributed polymer microparticles with average diameters between 2.0 and 6.6 µm within the cellulose matrix. Despite polymer inclusion, the water absorption value of the material still remained at ~50% of the original value and the material was able to release 32 g/100 cm<sup>2</sup> of the bound water. Mechanical characteristics were not impaired compared to the native material. The process was suitable for encapsulating the highly lipophilic drugs cannabidiol and 3-O-acetyl-11-keto-β-boswellic acid and enabled their sustained release with zero order kinetics over up to 10 days. Conclusively, controlled drug release for highly lipophilic compounds within bacterial nanocellulose could be achieved using sustainable solvents for preparation. | ||
546 | |a EN | ||
690 | |a bacterial nanocellulose | ||
690 | |a microparticles | ||
690 | |a PLGA | ||
690 | |a drug delivery | ||
690 | |a cannabidiol | ||
690 | |a boswellic acids | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceutics, Vol 15, Iss 2, p 559 (2023) | |
787 | 0 | |n https://www.mdpi.com/1999-4923/15/2/559 | |
787 | 0 | |n https://doaj.org/toc/1999-4923 | |
856 | 4 | 1 | |u https://doaj.org/article/d94e7b4cce28493c834e442d45c52c68 |z Connect to this object online. |